The present invention relates to phenanthrenyl imidazole; more particularly, relates to a phenanthrenyl-imidazole moiety reducing a band gap of a polymer to improve a photocurrent density and an optoelectrical transformation efficiency.
In recent years, there are a number of ways to improve power conversion efficiencies of solar cell, such as, varying annealing temperatures and time for lowering electrical resistance of devices and introducing lowered work function electrode. On the other hand, copolymerization of different conjugated monomer is investigated to change polymer structure. The material used is mainly poly-(3-hexylthiophene) (P3HT) to improve hot treatment and structure. In addition, an electron transferring moiety is introduced to a main chain of thiophene to obtain a better conjugated polymer. Therein, P3HT has an average photocurrent density of 10 mA/cm2; and a highest photocurrent density is 12 mA/cm2. However, the material is insufficient and the photocurrent density is still low. Hence, the prior arts do not fulfill users' requests on actual use.
The main purpose of the present invention is to reducing a band of poly(3-octyl-thiophene) (P3OT) and to improve its transference capacity.
To achieve the above purpose, the present invention is a soluble phenanthrenyl imidazole for photo-electrical conversion of a solar cell, where a first monomer and a second monomer, having phenanthrenyl imidazole, are obtained through syntheses and then are polymerized to obtain a thiophene polymer of phenanthrenyl imidazole through a Grignard metathesis (GRIM), having a chemical structure of
the first monomer is 2,5-dibromo-3-octylthiophene; the second monomer is 2,5-dibromo-phenanthrenyl imidazole thiophene; and the GRIM has a maximum adding ratio of 80% of the second monomer and 20% of the first monomer. Accordingly, a novel soluble phenanthrenyl imidazole for photo-electrical conversion of a solar cell is obtained.
The present invention will be better understood from the following detailed description of the preferred embodiment according to the present invention, taken in conjunction with the accompanying drawings, in which
The following description of the preferred embodiment is provided to understand the features and the structures of the present invention.
The present invention is a soluble phenanthrenyl imidazole for photo-electrical conversion of a solar cell, where a first monomer and a second monomer, which has phenanthrenyl imidazole, are obtained through syntheses; and then are polymerized through a Grignard metathesis (GRIM) to obtain a thiophene polymer of phenanthrenyl imidazole having a chemical structure of
Please refer to
(a) 3-bromothiophene [11] and C8H17MgBr [12] are reacted to obtain a first product [15], coordinated with a catalyzer (Ni(dppp)Cl2) [13] and ether [14], where the first product [15] is 3-octyl-thiophene and has a production ratio of 88%.
(b) The first product [15] and two equivalent N-bromosuccinimide (NBS) [16] are reacted to obtain a first monomer [17], where the first monomer [17] is poly(3-octyl-thiophene) (P3OT) and has a production ratio of 92%.
(c) thiophene-3-carboxaldehyde [18], aniline [19] and phenanthrenequinone [20] are reacted to obtained a second product [23] with an acetic acid (CH3COOH) [21] as a solvent for ammonium acetate (CH3COONH4) [22], where the second product [23] is 1 -Phenyl-2-(3-thioenyl)-1 H-phenanthro-dimidazole and has a production ratio of 90%.
(d) The second product [23] and two equivalent NBS [16] are reacted to obtain a second monomer [24] having a phenanthrenyl-imidazole moiety, where the second monomer [24] is phenanthrenyl imidazole thiophene and has a production ratio of 95%; and the functionality of phenanthrenyl-imidazole moiety is similar to oxidiazo-moiety, triazole-moiety, quinoxaline-moiety, imidazole-moiety or triazine-moiety
(e) And then, CH3MgBr [24] is obtained as a solvent for polymerizing the first monomer [17] and the second monomer [24] through a GRIM to obtain a thiophene polymer of phenanthrenyl imidazole [28], where the GRIM has a maximum adding ratio of 80% of the second monomer and 20% of the first monomer.
An indium tin oxide (ITO) glass is precleaned with oxygen plasma prior to use. A polymer/PCBM([6,6]-phenyl C61 -butyric acid methyl ester) is solved into a dichlorobenzene solution to 15 mg/mL at 40 Celsius degrees; and then is spin-coated with a thickness of 80 nanometers (nm) on the ITO glass at 1500 rpm. Calcium and aluminum are vacuum-deposited under a pressure below 10−6 torr, having a thickness of 30 nm and 100 nm respectively. Thus, a device having a material of phenanthrenyl imidazole is obtained.
The variable m and n shown in
An example of the derivation of P00 follows. The Mn is 11600, as shown in
Please further refer to
EHOMO=−Eox−4.4 eV and
ELUMO=−Ered−4.4 eV and
where Eox and Ered are the onset potentials of the oxidation and reduction peaks. A band gap exists between the EHOMO and the ELUMO. After introducing the phenanthrenyl-imidazole moiety, the HOMOs for P00 to P82 are increased from −5.40 electron volts (eV) to −5.15 eV; and the LUMOs are decreased from −3.75 eV to −3.55 eV. Thus phenanthrenyl-imidazole moiety increases effective conjugation length of polymers like P00 and P82 by improving coplanarity.
Please further refer to
Please further refer to
Please further refer to
Please refer to
To sum up, the present invention is a soluble phenanthrenyl imidazole for photo-electrical conversion of a solar cell, where a current density of a solar cell is greatly improved while a high photoelectrical transformation ratio remains; and thus a breakthrough happens to a solar cell promising a better efficiency in photoelectrical transformation.
The preferred embodiment herein disclosed is not intended to unnecessarily limit the scope of the invention. Therefore, simple modifications or variations belonging to the equivalent of the scope of the claims and the instructions disclosed herein for a patent are all within the scope of the present invention.
Number | Date | Country | Kind |
---|---|---|---|
95145634 | Dec 2006 | TW | national |
This application claims priority to under 35 U.S.C.§120 and is a continuation-in-part of pending U.S. application Ser. No. 11/705,609, filed Feb. 13, 2007, the entire contents of which are fully incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
7368510 | Lee et al. | May 2008 | B2 |
20040227128 | Reuter et al. | Nov 2004 | A1 |
Number | Date | Country | |
---|---|---|---|
20110028680 A1 | Feb 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11705609 | Feb 2007 | US |
Child | 12901619 | US |